Alzheimer’s drug donanemab finds late-stage trial success, safety concerns
By
Alicia Lasek
May 04, 2023
The experimental drug donanemab appears to halt the progression of Alzheimer’s disease and slow certain measures of clinical decline, new trial data show.
Seniors’ sense of smell weakens, but not their enjoyment of food, researchers find
By
Alicia Lasek
Jul 13, 2021
The sense of smell declines with age, but this loss doesn’t happen across the board, a new study shows. The findings may help care providers improve the meals and dining experiences of older adults in...
Program that diagnosed fractures virtually led to fewer ER visits for LTC residents: study
By
Alicia Lasek
May 14, 2023
A program that enabled virtual diagnosis and on-site fracture care kept 100% of participating LTC residents out of the emergency department and cut the need for clinic visits, a new study reveals.
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
Simultaneous flu and COVID shots work well in older adults, new study finds
By
Alicia Lasek
Nov 16, 2021
Given together, the vaccines are safe and spur a robust antibody response, a first-of-its-kind trial finds.
One in five at-risk patients reject statin therapy, large study finds
By
Alicia Lasek
Feb 28, 2023
More than 20% of patients at high risk for cardiovascular disease refuse to take recommended statin medications, and women are 50% more likely than men to opt out, finds a study involving 24,000 participants.
White House: COVID treatments should be part of ‘routine’ clinical care at nursing homes
By
Alicia Lasek
Oct 11, 2022
Nursing homes are on the front lines of not just preventing COVID-19, but also increasingly treating it, as more deaths from the disease shift from hospitals to that setting, officials say.
CDC: Two booster shots cut severe COVID risk in nursing home residents by 74 percent
By
Alicia Lasek
Oct 03, 2022
Nursing home residents who received a second mRNA booster shot during omicron were much less likely to suffer severe COVID-19 outcomes than their peers who received only one dose, a new study shows.
LTC residents have detectable antibodies 6 months after COVID vaccination
By
Alicia Lasek
Apr 12, 2021
All residents tested in University of Pittsburgh Medical Center Senior Communities were found to have antibodies against SARS-CoV-2 after full vaccination. The findings are “cautious good news,”...
APIC urges LTC industry to boost infection control capabilities with full-time, certified staff
By
Alicia Lasek
Mar 09, 2022
With the lessons of the pandemic fresh in mind, now is the time for LTC administrators to commit to recruiting and training dedicated, on-site infection preventionists, experts say. Sources of federal...